Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
10
×
national
10
×
national blog main
life sciences
national top stories
san francisco blog main
san francisco top stories
boston blog main
boston top stories
biotech
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
clinical trials
fda
roche
keytruda
loxo oncology
bristol-myers squibb
larotrectinib
merck
opdivo
pfizer
startups
yervoy
What
cancer
10
×
annual
medicine
cash
clinical
drug
oncology
society
today
conference
esmo
european
fda
genetic
home
intended
medical
meeting
new
patients
potential
prize
risks
roundup
seen
took
ahead
allison
ambien
american
analysis
anti
appetite
approved
asco
ash
attendees
attention
awarded
barcelona
Language
unset
Current search:
national
×
cancer
×
cancer
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Startup CureMatch Wins $35,000 Grand Prize in Global Trade Pitchfest
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More